Clinical trials
Ovarian Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
166 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 7 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 10 |
| 2023 | 12 |
| 2024 | 18 |
| 2025 | 15 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 62 |
| Recruiting | 45 |
| Active, not recruiting | 28 |
| Terminated | 23 |
| Unknown status | 7 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 13 |
| AbbVie | 8 |
| Eli Lilly and Company | 6 |
| Merck Sharp & Dohme LLC | 5 |
| Pfizer | 5 |
| Amgen | 4 |
| Daiichi Sankyo | 4 |
| Hoffmann-La Roche | 4 |
| Novartis Pharmaceuticals | 4 |
| Queensland Centre for Gynaecological Cancer | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 166 |
| Fallopian Tube Neoplasms | 40 |
| Breast Neoplasms | 36 |
| Carcinoma, Non-Small-Cell Lung | 36 |
| Endometrial Neoplasms | 35 |
| Colorectal Neoplasms | 34 |
| Pancreatic Neoplasms | 32 |
| Stomach Neoplasms | 29 |
| Uterine Cervical Neoplasms | 27 |
| Triple Negative Breast Neoplasms | 26 |
Trials
Showing 76 to 100 of 166. Each trial links to its page on Pharma Observatory.
66 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.